BACKGROUND: Determining both the frequency and the spectrum of p53 gene mutation in young patients with gastric cancer might provide clues to the host related genetic mechanism(s) in gastric carcinogenesis. PATIENTS AND METHODS: p53 mutations were assessed (by means of polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), followed by DNA sequencing) in a cohort of 105 consecutive Italian patients in whom gastric cancer was ascertained before the age of 41. RESULTS: A low prevalence of p53 mutations (eight of 105) was observed, with no significant difference between intestinal (three of 31; 10%) and diffuse (five of 74; 7%) phenotypes. A significantly higher prevalence of p53 mutations was associated with the cardiac location (odds ratio, 7.09; confidence interval, 1.56 to 32.11). In all but one case, p53 mutations were associated with a stage higher than I. All eight mutations were located at CpG sites, where G : C to A : T transitions have been associated with frequent methylation at the C5 position of cytosine. CONCLUSIONS: These findings show that, unlike what has been consistently demonstrated in the general population, p53 mutations are uncommon in gastric cancer occurring in young patients, and in such patients, p53 alterations are significantly associated with the cardiac location.
BACKGROUND: Determining both the frequency and the spectrum of p53 gene mutation in young patients with gastric cancer might provide clues to the host related genetic mechanism(s) in gastric carcinogenesis. PATIENTS AND METHODS: p53 mutations were assessed (by means of polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), followed by DNA sequencing) in a cohort of 105 consecutive Italian patients in whom gastric cancer was ascertained before the age of 41. RESULTS: A low prevalence of p53 mutations (eight of 105) was observed, with no significant difference between intestinal (three of 31; 10%) and diffuse (five of 74; 7%) phenotypes. A significantly higher prevalence of p53 mutations was associated with the cardiac location (odds ratio, 7.09; confidence interval, 1.56 to 32.11). In all but one case, p53 mutations were associated with a stage higher than I. All eight mutations were located at CpG sites, where G : C to A : T transitions have been associated with frequent methylation at the C5 position of cytosine. CONCLUSIONS: These findings show that, unlike what has been consistently demonstrated in the general population, p53 mutations are uncommon in gastric cancer occurring in young patients, and in such patients, p53 alterations are significantly associated with the cardiac location.
Authors: E Buiatti; D Palli; S Bianchi; A Decarli; D Amadori; C Avellini; F Cipriani; P Cocco; A Giacosa; L Lorenzini Journal: Int J Cancer Date: 1991-05-30 Impact factor: 7.396
Authors: T Hongyo; G S Buzard; D Palli; C M Weghorst; A Amorosi; M Galli; N E Caporaso; J F Fraumeni; J M Rice Journal: Cancer Res Date: 1995-06-15 Impact factor: 12.701
Authors: Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi Journal: World J Gastroenterol Date: 2011-01-21 Impact factor: 5.742
Authors: B G Schneider; S Y Rha; H C Chung; J C Bravo; R Mera; J C Torres; K T Plaisance; R Schlegel; C M McBride; X T Reveles; R J Leach Journal: Mol Pathol Date: 2003-06
Authors: Manzoor A Dhobi; Khursheed Alam Wani; Fazl Qadir Parray; Rouf A Wani; Mohd Lateef Wani; G Q Peer; Safiya Abdullah; Imtiyaz A Wani; Muneer A Wani; Mubashir A Shah; Natasha Thakur Journal: Int J Surg Oncol Date: 2013-12-07
Authors: Hee Jin Kim; Nayoung Kim; Hyuk Yoon; Yoon Jin Choi; Ju Yup Lee; Yong Hwan Kwon; Kichul Yoon; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Hye Seung Lee; Dong Ho Lee Journal: Gut Liver Date: 2016-03 Impact factor: 4.519